Alexander Zhyvoloup

Title: Alexander Zhyvoloup: Innovator in mTOR Research

Introduction

Alexander Zhyvoloup is a notable inventor based in Slough, GB. He has made significant contributions to the field of molecular biology, particularly in the study of the mammalian target of rapamycin (mTOR) protein. His innovative work has implications for understanding and treating diseases associated with mTOR dysregulation.

Latest Patents

Zhyvoloup holds a patent for a truncated variant of the mTOR protein, specifically mTORbeta. This invention encompasses nucleic acids encoding mTORbeta, antibodies against mTORbeta, and methods for producing and screening agents that modulate mTORbeta expression and activity. Furthermore, the patent outlines a method for treating diseases linked to aberrant mTORbeta expression through the administration of agents that alter mTOR activity and expression. He has 1 patent to his name.

Career Highlights

Throughout his career, Zhyvoloup has worked with prominent organizations, including UCL Business Plc and the Ludwig Institute for Cancer Research Limited. His roles in these institutions have allowed him to advance his research and contribute to significant scientific discoveries.

Collaborations

Zhyvoloup has collaborated with esteemed colleagues such as Ivan Nemazanyy and Ganna Panasyuk. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Alexander Zhyvoloup's contributions to mTOR research highlight his role as an influential inventor in the field of molecular biology. His patent on mTORbeta represents a significant advancement in understanding and potentially treating diseases related to this critical protein.